Introduction
============

Information from review of medical charts is often used to carry out audits, perform non-interventional observational studies, create disease registries, and do other types of health services research. Informed consent is not always necessary for these types of research, which involve abstraction of data from patients' records. Many such studies do not influence practice or patients' outcomes and therefore confer no risk and no benefit to participants. That notwithstanding, recent legislation to protect the privacy and confidentiality of patients' information in medical research introduced in many jurisdictions (for example, the regulations to the Health Insurance Portability and Accountability Act in the United States) has resulted in increased requests from research ethics boards to obtain informed consent to use data from medical records for such observational studies.[@ref1] As early as 1977 concerns were voiced about the possible negative impact of privacy laws on epidemiological research.[@ref2] More recently, editorial reviews highlighted the negative impact of mandatory informed consent on observational research through conservative interpretation of privacy legislation.[@ref3] [@ref4] [@ref5]

As with many other aspects of research, requirements for informed consent to use data from medical records vary across research ethics boards within and among countries. For example, in a multisite study involving a review of children's charts who presented to emergency departments with bronchiolitis, 34 research ethics boards arrived at divergent requirements for consent at their institutions, ranging from none to mandatory written consent.[@ref6] Four of the invited 34 sites did not participate owing to the investigator perceived hurdles with research ethics boards pertaining to informed consent.

Of greater concern is the impact of informed consent on the validity of the research in observational studies, audits, or registries. Mandatory informed consent in such no risk or low risk studies can create challenges to implementation and biased results. For example, in the Canadian Stroke Registry, investigators identified important differences between participants and non-participants in prognostic characteristics.^w1^ The selection bias introduced by informed consent was sufficiently serious to jeopardise the overall validity of the study, and investigators effectively shut down the registry by discontinuing follow-up surveys and record linkage studies.^w1^ Furthermore, case studies documenting the challenges of implementing informed consent recently reported low consent rates and poor efficiency of recruitment.^w1\ w2^

The primary objective of our systematic review was to determine whether informed consent for use of data from medical records introduces selection bias by examining differences in key personal characteristics between participants and non-participants in prospective observational studies requiring informed consent for access to medical records. Our secondary objective was to determine the rates of consent in these studies.

Methods
=======

We sought all studies reporting characteristics of participants and non-participants approached for informed consent to use data from their medical records for prospective observational studies or registries. We included studies reporting at least one of the following characteristics: age, sex, race, education, income, or health status. We also included studies that requested consent for access to medical records in addition to self administered or interview administered surveys or biological samples. However, we excluded studies of interventions (for example, randomised controlled trials) and studies using self administered or interviewer administered surveys or biological samples (for example, biobanks) alone. Owing to limitations on resources, we included only English language studies.

After consultation with a librarian in health sciences, we searched Embase (1980 to week 13 2008), Medline (1966 to March week 3 2008), and the Cochrane Library (Issue 1, 2008) (see web extra appendix A for full search strategy). To identify further articles from each included study, we searched reference lists, used the PubMed "related articles" feature, carried out a search of cited references in Thompson Scientific (Web of Science), and used the Google Scholar "cited by" feature.

Independently and in duplicate (MEK, MD) we scanned citations first by title and then by abstract. We reviewed full reports of all potentially relevant abstracts and calculated inter-rater reliability for included studies using the ? statistic. We subsequently resolved all disagreements through consensus; an independent adjudicator (MCB) resolved outstanding disagreements. Study population and setting, disease status, and recruitment methods were extracted.

We calculated the participation rate in each study[@ref7] and assessed the susceptibility of calculations on participation rate against threats of selection and reporting bias.[@ref8] For each study we determined the number of eligible participants, number approached for consent, number who responded to the request for consent, number of active consents, and number of active declines.

Heterogeneity among the studies in study design, recruitment methods, requests for consent, populations enrolled, and research settings precluded quantitative synthesis of the data.[@ref9] [@ref10] We used RevMan v 4.2.8 (Cochrane Collaboration) to calculate odds ratios (binary data), weighted mean differences (continuous data), and 95% confidence intervals. We used the ?^2^ statistic for comparisons of nominal data (\>2 categories)[@ref11] using SPSS version 16.0.

Results
=======

The electronic search identified 1650 citations, of which 128 were duplicates and 1335 were excluded after review of the title or abstract. Of 187 publications reviewed in full, 24 representing 23 unique studies met the eligibility criteria.^w1-w24^ The inter-rater reliability for included studies was 0.84 (95% confidence interval 0.83 to 0.86). Of the 23 eligible studies, 17 reported sufficient information for analyses of participants and non-participants and form the basis of this review.^w1\ w2\ w4\ w5\ w7\ w8\ w10-w13\ w15\ w16\ w18-w21\ w23\ w24^ The figure[](#fig1){ref-type="fig"} outlines the flow of included studies[@ref12] and table 1[](#tbl1){ref-type="table"} summarises the characteristics of the studies.

![Flow diagram of included studies. \*Two separate publications reported different outcomes from same study^w18\ w19^](khom601724.f1_default){#fig1}

###### 

Characteristics of included studies

  Study                                          Setting                                                                    Eligible participants                                                                                                   Recruitment methods                                                                                                                              Authorisation request                                                                                                                                                                      Reported outcomes
  ---------------------------------------------- -------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ --------------------------------------------------
  Bryant 2006^w4^                                Cohort study, Canada                                                       English speaking adults aged between 35 and 69 with no known history of cancer, residing in Alberta                     Random digit dialling and interview by research team, recruitment period October 2000 to June 2002                                               Request for periodic data linkages with Alberta cancer registry and data on utilisation of health services                                                                                 Age, sex
  Buckley 2007^w5^                               Cohort study, Ireland; multicentre (n=35)                                  Adults with established ischaemic heart disease                                                                         Postal survey from researchers, recruitment period not stated (follow-up of CoHeart Study)                                                       Request for access to medical records, survey                                                                                                                                              Age, sex, income, health status
  Dunn 2004^w7^                                  Cohort study, UK; multicentre (1-5 centres, depending on study)            Adults meeting eligibility criteria for six different studies                                                           Postal survey (senders unspecified), recruitment period August 1996 to June 2002                                                                 Separate requests for access to medical records and future contact                                                                                                                         Age, sex
  Edlund 1985^w8^                                Cohort study, USA; single centre                                           Adult inpatients with tardive dyskinesia                                                                                Personal contact in hospital (recruiters unspecified), recruitment period not reported                                                           Request for access to medical records                                                                                                                                                      Age
  Harris 2004^w10^                               Cohort study, UK; two centres                                              Adults aged more than 65 from two London practices                                                                      Postal survey (senders unspecified), recruitment period not stated                                                                               Separate requests for access to medical records, survey or questionnaire                                                                                                                   Age, sex, race, income, health status
  Huang 2007^w11^                                Cohort study, Taiwan                                                       Adults aged 20 or more from 2001 Taiwanese National Health Interview Survey with valid identification number            Personal contact by researchers, recruitment period not reported                                                                                 Request for access to national health insurance records                                                                                                                                    Age, sex, race, income, education, health status
  Jacobsen 1999^w12^                             Registry, USA; single centre                                               Adult outpatients receiving medical care at Mayo Clinic, Rochester, MN                                                  Postal survey from researchers, recruitment period January to April 1997                                                                         Request for access to medical records                                                                                                                                                      Age, sex, health status (Charlson comorbidity)
  Klassen 2005; NICU and healthy children^w13^   Cohort study, Canada; two centres                                          Children born between 1996 and 1997 in two British Columbia hospitals and three NICUs                                   Postal survey from researchers, recruitment period not stated                                                                                    NICU and healthy children; separate requests for access to medical records (mother and baby), survey                                                                                       Maternal age, sex, income
  Matsui 2005; non-genetic and genetic^w15^      Cohort study, Japan; Takashima study                                       Adults from geographical catchments in four Japanese areas attending annual health check up                             Personal contact by researchers, physicians and nurses, recruitment period 2002-3                                                                Non-genetic: two catchments, separate requests for access to medical records, survey, blood sample; genetic: two catchments, same as for non-genetic plus genetic analysis, DNA analysis   Sex
  McKinney 2005^w16^                             Registry, England; multicentre (n=5)                                       Children admitted to PICU                                                                                               Personal contact by PICU staff, recruitment period May to July 2003                                                                              Request for access to medical records                                                                                                                                                      Age, sex, race, income, health status
  Schwartz 2005^w19^; Phipps 2004^w18^           Registry, USA; three centres                                               Adults with stroke or traumatic brain injury from 1 of 3 rehabilitation service systems in south eastern Pennsylvania   Personal contact at clinic by "site recruiters", recruitment period not specified                                                                Separate requests for medical records and future contact                                                                                                                                   Age, sex, race
  Tate 2006^w20^                                 Cohort study, UK; Millennium cohort                                        Children born between September 2000 and January 2002                                                                   Personal contact, recruitment period not stated                                                                                                  Request for access to medical records (mother and baby)                                                                                                                                    Maternal age, race, income, education
  Tu 2004; phases I and II^w1^                   Registry, Canada; multicentre (n=20), Canadian Stroke Registry Network     Adults with acute stroke, transient ischaemic attacks, or both                                                          Personal contact in hospital by research nurses, two recruitment phases: June 2001 to February 2002, June 2002 to December 2002                  Separate requests for access to medical records, future contact, interview, release of aggregate data to commercial organisation                                                           Age, sex, race
  Woolf 2000^w21^                                Registry, USA; single centre                                               Adults in primary care for practice based research network                                                              Personal contact by clinic administrative staff, recruitment May to November 1999                                                                Combined request for access to medical records and future contact                                                                                                                          Age, sex, race, income, education, health status
  Yawn 1998^w23^                                 Registry, USA; single centre                                               Adult and paediatric attendees at medical centre                                                                        Personal contact and postal survey (emergency department patients) by administrative clinic staff, recruitment period January to February 1997   Request for access to medical records                                                                                                                                                      Age, sex
  Young 2001^w24^                                Cohort study, Australia; Australian Longitudinal Study on Women's Health   Women participating in Australian Longitudinal Study on Women's Health                                                  Postal survey from researchers, recruitment period March 1997                                                                                    Request for access to medical records                                                                                                                                                      Age, education

NICU=neonatal intensive care unit; PICU=paediatric intensive care unit.

Participation rates and susceptibility to bias
----------------------------------------------

All 17 studies described eligibility criteria. Three disclosed no information on how investigators identified eligible participants for informed consent.^w15\ w19\ w23^ Four approached all eligible participants and two randomly selected eligible participants.^w12\ w21^ In five studies, investigators were prevented from approaching all potentially eligible participants owing to physician approval,^w1\ w2\ w5^ patient availability,^w1^ and study specific barriers.^w13^ All but one study presented sufficient information to reconstruct the outcomes of participation (table 1).^w15^

Of 161?604 eligible patients in the 17 studies, 108?033 (66.9%, 95% confidence interval 66.6% to 67.1%) provided active consent for use of data from their medical records. Consent rates for eligible participants varied across the studies (from 36.6%^w21^ to 92.9%^w20^) and approximated a normal distribution (not shown). Table 2[](#tbl2){ref-type="table"} outlines the methodological information related to obtaining consent and table 3[](#tbl3){ref-type="table"} outlines the rates of participation in each study.

###### 

Methodological elements to describe informed consent

  Study                                 Element                                                                                                                                                                                                      
  ------------------------------------- --------- ----- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----
  Al-Shahi 2005^w2^                     Yes       No    Approval by general practitioner or hospital consultant                                                                                                                                      Yes
  Bryant 2006^w4^                       Yes       Yes   NA                                                                                                                                                                                           Yes
  Buckley^w5^                           Yes       No    Contact by general practitioner                                                                                                                                                              Yes
  Dunn 2004^w7^                         Yes       Yes   NA                                                                                                                                                                                           Yes
  Edlund 1985^w8^                       Yes       Yes   NA                                                                                                                                                                                           Yes
  Harris 2004^w10^                      Yes       No    Approval by general practitioner or district nurses, no dementia, alive and living in practice area; on the electoral register and had contact with the practice within the last 5 years\*   Yes
  Huang 2007^w11^                       Yes       Yes   NA                                                                                                                                                                                           Yes
  Jacobsen 1999^w12^                    Yes       Yes   Random selection                                                                                                                                                                             Yes
  Klassen 2005; healthy children^w13^   Yes       No    Ability to contact, English language, vital status of mother or baby                                                                                                                         Yes
  Klassen 2005; NICU^w13^               Yes       No    Ability to contact, English language, vital status of mother or baby                                                                                                                         Yes
  Matsui; genetic 2005^w15^             Yes       No    Not stated                                                                                                                                                                                   No
  Matsui; non-genetic 2005^w15^         Yes       No    Not stated                                                                                                                                                                                   No
  McKinney 2005^w16^                    Yes       No    Not stated                                                                                                                                                                                   Yes
  Schwartz 2005^w19^                    Yes       No    Not stated                                                                                                                                                                                   No
  Tate 2006^w20^                        Yes       Yes   NA                                                                                                                                                                                           Yes
  Tu 2004; phase I^w1^                  Yes       No    Doctor approval, patient availability                                                                                                                                                        Yes
  Tu 2004; phase II^w1^                 Yes       No    Doctor approval, patient availability                                                                                                                                                        Yes
  Woolf 2000^w21^                       Yes       Yes   Random selection                                                                                                                                                                             Yes
  Yawn 1998^w23^                        Yes       No    Not stated                                                                                                                                                                                   Yes
  Young 2001^w24^                       Yes       Yes   NA                                                                                                                                                                                           Yes

NICU=neonatal intensive care unit; NA=not available. Criteria informed by Guyatt and Rennie.^8^

\*Reasons for exclusion reported in Harris et al.^13^

###### 

Participation rates by study and associated participation rates

  Study                                 Eligible   Approached   Responded   Active consent   Active decline   No response   Not approached   Participation rate (%)
  ------------------------------------- ---------- ------------ ----------- ---------------- ---------------- ------------- ---------------- ------------------------
  Al-Shahi 2005^w2^                     187        131          111         111              0                20            56               59.4
  Bryant 2006^w4^                       11 865\*   11 865       11 865      11 525           338              0             0                97.1
  Buckley 2007^w5^                      1383†      1269         876         574              302              393           114              41.5
  Dunn 2004^w7^                         33 101     33 101       22 644      18 172           4472             11 239        0                53.6
  Edlund 1985^w8^                       93         93           93          40               53               0             0                43.0
  Harris 2004^w10^                      2843‡      2276         1704        1565             139              572           567§             55.0
  Huang 2007^w11^                       15 413¶    15 413       15 413      13 504\*\*       1909             0             0                87.6
  Jacobsen 1999^w12^                    2463       2463         2023        1941††           82               440††         0                78.8
  Klassen 2005; healthy children^w13^   691        592          393         274              119              199           126              38.2
  Klassen 2005; NICU^w13^               2098       1692         1140        832              308              552           529              37.5
  Matsui; genetic 2005^w15^             2195       NR           2195        1855             340‡‡            84.5                           
  Matsui; non-genetic 2005^w15^         3166       NR           3166        2900             266‡‡            91.6                           
  McKinney 2005^w16^                    422        183          183         182              1                0             239              43.1
  Schwartz 2005^w19^                    2422       2164         1817        1256             563              346           258              51.9
  Tate 2006^w20^                        18 505     18 505       17 221      17 195           26               1284          0                92.9
  Tu 2004; phase I^w1^                  4825       2078         2078        1684             394              0             2207§§           39.3
  Tu 2004; phase II^w1^                 2823       1761         1761        1428             333              0             1062§§           50.6
  Woolf 2000^w21^                       1229       1106         1021        743              278              85            123              36.3
  Yawn 1998^w23^                        15 997     15 789       15 069      14 493           576              720           208              90.6
  Young 2001^w24^                       39 883     39 883       20 864      19 700           1164             19 019        0                49.3

NR-not reported.

\*Includes two transgendered people for whom consent information was not available.

†Authors reported 1609 eligible; we adjusted this number to 1383 after excluding 226 from the original cohort who were dead at the time of the follow-up study and not eligible for inclusion.

‡Number eligible reported in Harris et al.^13^

§Reasons for not being approached reported in Harris et al.^13^

¶802 of 15 413 eligible people did not complete all parts of demographic survey and were not included in demographic analyses.

\*\*Includes 593 people who consented to access of data from medical records but did not complete all parts of demographic survey.

††Per authors, non-respondents were considered as positive consent per Minnesota law. Table includes those who actively consented.

‡‡Aggregate data reported.

§§Not approached because of language barrier, surrogate decision maker unavailable and other, and patients died or left hospital.

Differences between participants and non-participants
-----------------------------------------------------

Authors represented the characteristics of participants and non-participants in four different ways: continuous data,^w1\ w2\ w8\ w11\ w21^ proportions,^w1\ w2\ w4\ w5\ w7\ w10\ w11\ w19\ w21\ w23\ w24^ regression analyses,^w13^ and the weighted proportion of patients declining consent after adjustment for study design.^w12\ w20^ Studies reported comparisons between participants and non-participants with different denominators: four studies reported consent of those eligible,^w1\ w2\ w16\ w23^ eight of those approached,^w4\ w7\ w8\ w12\ w19-w21\ w24^ and four of those who responded.^w5\ w10\ w13\ w15^ One study reported the denominator for consent on the basis of the availability of personal characteristics.^w11^ We describe comparisons between participants and non-participants according to age, sex, race, income, education, and health status. Table 4[](#tbl4){ref-type="table"} summarises differences by these outcomes.

###### 

Summary of differences between participants and non-participants by study

  Study                                            Personal characteristics                                                                                                                                                                                           
  ------------------------------------------------ -------------------------------------- ------------------------------------------------------ --------------------------------- ----------------------------------- ---------------------------------------------- ---------------------------------------------------------------------------------
  Al-Shahi 2005^w2^                                NS                                     NS                                                     NR                                NS                                  NR                                             Less disability (Rankin score); P\<0.001
  Bryant 2006^w4^                                  Varied by age strata; P\<0.001         More females: odds ratio 2.21 (95% CI 1.77 to 2.75)    NR                                NR                                  NR                                             NR
  Buckley 2007^w5^                                 NS                                     Fewer females: odds ratio 0.73 (95% CI 0.54 to 0.97)   NR                                NS                                  NR                                             NR
  Dunn 2004^w7^                                    Varied by age strata; P\<0.001         More females: odds ratio 1.07 (95% CI 1.03 to 1.12)    NR                                NR                                  NR                                             NR
  Edlund 1985^w8^                                  NS                                     NR                                                     NR                                NR                                  NR                                             NR
  Harris 2004^w10^                                 NS                                     NS                                                     NS                                NS                                  NR                                             More disability (disability score); P\<0.001
  Huang 2007^w11^                                  Varied by age strata; P\<0.001         Fewer females: odds ratio 0.90 (95% CI 0.81 to 1.0)    Varied by race strata; P\<0.001   Varied by income strata; P\<0.001   Varied by education strata; P\<0.001           Varied by SF-36 subscale
  Jacobsen 1999^w12^                               Varied by age strata; P\<0.001         NS                                                     NR                                NR                                  NR                                             More comorbidity (Charlson index =2); P=0.008
  Klassen 2005; healthy^w13^                       NS                                     NS                                                     NR                                Varied by income strata             NS                                             NR
  Klassen 2005; NICU^w13^                          NS                                     NS                                                     NR                                NS                                  NS                                             NR
  Matsui; genetic 2005^w15^                        NR                                     NS                                                     NR                                NR                                  NR                                             NR
  Matsui; non-genetic 2005^w15^                    NR                                     Fewer females: odds ratio 0.62 (95% CI 0.46 to 0.82)   NR                                NR                                  NR                                             NR
  McKinney 2005^w16^                               NS                                     NS                                                     NS                                NS                                  NR                                             Varied by paediatric risk of mortality score; P=0.024
  Schwartz 2005^w19^ and Phipps 2004^w18^ (race)   Younger: 58.7 (20.2) *v* 67.7 (18.6)   Fewer females: odds ratio 0.67 (95% CI 0.49 to 0.91)   NS                                NR                                  Varied by education strata; P=0.019            NR
  Tate 2006^w20^                                   Varied by age strata                   NR                                                     Varied by race strata             Varied by income strata             Varied by education strata                     NR
  Tu 2004; phase I^w1^                             Younger; 69 *v* 72, P\<0.001           NS                                                     Varied by race strata; P\<0.001   NR                                  NR                                             NR
  Tu 2004; phase II^w1^                            NS                                     Fewer females: odds ratio 0.79 (95% CI 0.68 to 0.91)   Varied by race strata; P\<0.001   NR                                  NR                                             NR
  Woolf 2000^w21^                                  NS                                     Fewer females: odds ratio 0.59 (95% CI 0.42 to 0.81)   Fewer black patients; P=0.013     NS                                  NS                                             More physical disability; weighted mean difference -2.5 (95% CI -3.98 to -1.02)
  Yawn 1998^w23^                                   Varied by age strata; P=0.018          NS                                                     NR                                NR                                  NR                                             NR
  Young 2001^w24^                                  Varied by age strata; P\<0.001         NR                                                     NR                                NR                                  More education beyond school level; P\<0.001   NR

NR=not reported; NS=no statistically significant difference between participants and non-participants. See web extra appendix B for detailed information on each characteristic.

*Age---*Sixteen studies reported characteristics of the participants and non-participants by age (see web extra appendix B1).^w1\ w2\ w4\ w5\ w7\ w8\ w10-w13\ w16\ w19-w21\ w23\ w24^ Seven studies found no age related differences,^w2\ w5\ w8\ w10\ w13\ w16\ w21^ one found that participants were younger than non-participants,^w19^ and seven identified significant differences across age strata; however, no clear pattern emerged.^w4\ w7\ w11\ w12\ w20\ w23\ w24^ In the Canadian Stroke Registry Network, participants in phase I of the study were younger than non-participants, whereas in phase II there were no differences^w1^ after a change in recruitment strategy.

*Sex---*Fourteen studies that recruited both males and females reported the characteristics of participants and non-participants by sex (see web extra appendix B2).^w1\ w2\ w4\ w5\ w7\ w10-w13\ w15\ w16\ w19\ w21\ w23^ Six studies reported no differences in the odds of females participating compared with males.^w2\ w10\ w12\ w13\ w16\ w23^ In the six studies where there were differences, two determined that females were more likely to consent than males,^w4\ w7^ whereas four determined that females were less likely to consent than males.^w5\ w11\ w19\ w21^ In the remaining two studies the participation of females differed between subgroups. In the Takashima cohort study there was no difference in the likelihood of participation between females and males enrolled in a group requesting access to their medical records in addition to surveys and a blood sample. However, females were less likely to participate than males with the addition of genetic testing to the request for access to medical records, surveys, and a blood sample.^w15^ The Canadian Stroke Registry Network initially had no differences in participation rates between the sexes; after a change in recruitment strategy fewer females than males participated.^w1^

*Race---*Six studies reported the characteristics of participants and non-participants by race (see web extra appendix B3).^w1\ w10\ w11\ w18\ w20\ w21^ Two found no difference in the odds of obtaining consent by race.^w10\ w18^ Three studies determined higher participation rates in white or Caucasian patients than others,^w1\ w20\ w21^ and a Taiwanese study of national health records identified differences across four strata of race.^w11^

*Income---*Seven publications reported participants and non-participants by income (see web extra appendix B4).^w5\ w10\ w11\ w13\ w16\ w20\ w21^ Four studies found no differences by income.^w5\ w10\ w16\ w21^ Across five strata of income, Huang et al^w11^ identified varying rates of participation for access to Taiwanese National Health Insurance records. Another study reported no differences in income in parents of babies in neonatal intensive care units, whereas there were differences across income categories in parents of healthy babies.^w13^ Women who never worked or who were unemployed long term were less likely to participate in the UK millennium cohort study; however, after adjusting for education, socioeconomic status did not independently predict participation.^w20^

*Education---*Six studies reported participants and non-participants by education (see web extra appendix B5).^w11\ w13\ w19-w21\ w24^ Two studies found no differences related to education^w13\ w21^; however, in the Australian Longitudinal Study on Women's Health, those women who had continued their education beyond school were more likely to participate. Three studies that described participants and non-participants by strata identified significant differences, although no clear patterns emerged.^w11\ w19\ w20^

*Health status---*All six studies that reported health status found differences between participants and non-participants (see web extra appendix B6).^w2\ w10-w12\ w16\ w21^ In two studies participants had more disability or comorbidity than non-participants as measured by the Charlson comorbidity index^w12^ and the physical components summary.^w21^ Two studies reported that participants had less disability than non-participants as measured by the modified Rankin score^w2^ and disability score.^w10^ One study reported higher SF-36 subscale scores in physical function, role physical, vitality, and general health in participants and no differences in role emotional, social functioning, bodily pain, and mental health.^w11^ In a study that enrolled patients from the paediatric intensive care unit, participation varied by strata for risk of death.^w16^

Discussion
==========

Bias results in systematic deviation from the underlying truth.[@ref8] Jacobsen et al used the term authorisation bias to describe statistically significant differences between participants and non-participants in research that used medical records.^w12^ In this systematic review we identified 17 unique studies comparing participants and non-participants in observational studies that requested access to medical records. Across all outcomes there were differences between participants and non-participants, although there was a lack of consistency in the direction and the magnitude of effect. Thus although results of this systematic review suggest that requirements for informed consent introduced a variety of biases into prospective observational studies using data from medical records, no systematic deviations occurred and the cause of the differences by age, sex, race, income, education, or health status that did emerge is unclear. Most studies did not explore reasons for refusal, non-response, or inability to contact patients. This is an important gap, as failure to ask for consent may indicate deficiencies in organisational planning that call for a different policy response than does refusal to participate. At this stage the state of the research is such that our ability to predict these differences with confidence and to guide researchers to avoid authorisation bias is limited.

In terms of our secondary objective, participation rates varied substantially. Studies with high participation rates showed selection biases, the proportion of eligible participants approached for enrolment differed across studies and we identified opportunities to improve the reporting of outcomes for consent. Whereas all studies reported how investigators identified eligible people, four did not report how those eligible were chosen for participation.^w15\ w16\ w19\ w23^ Knowing such information helps us to better interpret how susceptible these four studies were to selection bias before the introduction of informed consent.

Our review indicates that consent rates for studies using medical records vary considerably, affecting recruitment efforts and potentially influencing study results. Accordingly, consideration of these factors in the study design, planning, and budgeting is essential. Willison et al offered practical advice for studies based on consent at local and systems levels after their experiences of involving multisites in the Canadian Stroke Registry Network, such as testing the consent process by using a pilot, close communication with research ethics boards and healthcare institutions, consideration of random sampling strategies, and ongoing monitoring and feedback on accrual.[@ref14] Recent recommendations reinforce the explicit reporting of personal comparisons between participants and non-participants as an important feature of publications on observational studies.[@ref15] Future research needs to systematically study why otherwise eligible patients are not approached for consent and the characteristics of patients associated with refusal to participate in studies using medical records.

Pragmatically what should researchers planning a prospective observational study that involves medical records do? The United Kingdom National Health Service Act 2006 (Section 251),[@ref16] the common rule of the Health Insurance Portability and Accountability Act,[@ref17] and the Canadian Institutes for Health Research[@ref18] offer guidance to researchers on informed consent for research involving medical records. Although consent is required for the collection of personal information from participants for medical procedures, medical examinations, and clinical trials, exemption from requiring consent may be appropriate for studies using medical records owing to impracticability of informed consent and the possibility of introducing biased study results.[@ref18]

We suggest requesting a waiver of consent from the research ethics board for research using medical records because these studies confer no or minimal risk, do not directly benefit the patient, and because of the potential biases introduced through loss of data in ways that are not completely at random. We suggest explicitly outlining the procedures the research team will take to protect the privacy and confidentiality of each patient. For example, to minimise the risks of a breach of confidentiality, researchers could collect the minimum personal information necessary for identification from each record and incorporate strict access policies to the data at patient level.

However, if a waiver of consent is not possible, as in some European Union jurisdictions,[@ref19] we suggest collecting a minimum dataset of key prognostic variables on all eligible people for the study identified through screening. These data can be used to carry out a preliminary analysis comparing participants with non-participants on the key prognostic variables at predetermined times during study accrual, taking into account statistical adjustments for multiple significance testing. Such an approach may lead to revised recruitment strategies to address these concerns---for example, tailored recruitment, targeting participation of populations less likely to grant consent.

On the basis of findings from this review, the validity of results from observational studies that require consent for access to medical records may be threatened as a result of significant differences between participants and non-participants. Across the continuum of research we suggest three strategies to minimise the impact of authorisation bias at the inception, reporting, and interpretation of research. At inception we suggest widespread education aimed at clinicians, researchers, and research ethics boards on the conditions under which studies can proceed without individual consent. To help us better interpret differences between participants and non-participants we suggest standardised reporting of methods used to seek informed consent. We believe the elements we report in table 2 provide the minimum dataset for these purposes and could serve as the foundation for expectations on quality reporting. Similarly, we advocate standardised key metrics on informed consent such as participation rates, including eligible, approached, responded, active consent, and active declines (see table 3). Finally, in interpreting observational studies that exhibit significant differences between participants and non-participants, clinicians and researchers should be aware of differences in important prognostic variables and their possible impact on study results. The box summarises our recommended strategies to minimise the impact of bias from informed consent.

Five suggested strategies to minimise the impact of bias from informed consent
------------------------------------------------------------------------------

1.  Request a waiver of consent from research ethics boards and explicitly outline procedures to protect the privacy and confidentiality of each patient

2.  If a waiver is not possible then:

    1.  Collect a minimum dataset of key prognostic variables on all eligible people identified through screening

    2.  Complete a preliminary analysis comparing participants and non-participants on key prognostic variables at predetermined times

    3.  Revise the strategy for recruitment as necessary

3.  Aim education at clinicians, researchers, and research ethics boards on conditions under which studies can proceed without individual consent

4.  Standardise reporting of methods used to seek informed consent

5.  Increase awareness by clinicians and researchers of the potential impact of selection bias introduced by informed consent and implications for interpretation of the study

Strengths and limitations of the study
--------------------------------------

Our review has several strengths. A priori we developed comprehensive search strategies with librarians in health sciences who were familiar with the indexing methods of electronic databases on health. We included both Medline and Embase, which are complementary bibliographic databases of the biomedical literature[@ref20]; we supplemented included articles with searches of cited references and related articles. We used broad search strategies of published literature and reviewed all citations and included studies in duplicate that resulted in good agreement and transparent reporting.[@ref10] [@ref12]

Our review also has limitations. Our search included only studies in English available in the peer review literature. Because of the variability in results we do not expect exclusion of non-English studies to impair the generalisability of our findings; however, this hypothesis needs to be confirmed in future research. Our review was limited by the published reports, including lack of clarity about the sample size and reporting standards for screening and consent procedures. Not all studies reported data on our outcomes of interest; authors may not have collected data on these outcomes or chose to report only significant differences between participants and non-participants.^w7\ w20\ w24^ For example, of the two studies reporting all six of our outcomes of interest, one identified statistically significant differences by sex, race, and health status and no differences by age, income, or education,^w21^ whereas the other study identified significant differences by age, race, income, education, and health status and no differences by sex.^w11^ Because these observational studies were not specifically designed to study differences in consent between participants and non-participants, we may have observed statistically significant differences across our outcomes of interest simply by chance.[@ref8]

Conclusion
----------

In conclusion, we observed authorisation bias in studies requiring informed consent for use of data from medical records. To assess better the impact of informed consent on prospective observational studies, consistent reporting of core personal factors of known prognostic significance between the characteristics of participants and non-participants is necessary. To ensure that legislation on privacy does not unduly threaten the validity of observational studies using data from medical records, education of bodies responsible for overseeing research and further investigations are urgently needed on the determinants and consequences of consent and non-consent for these studies.

### What is already known on this topic

1.  Privacy legislation has resulted in some research ethics boards requiring informed consent to use medical records

2.  Whether mandatory informed consent creates selection bias in these observational studies is unknown

### What this study adds

1.  Of 1650 citations, 17 unique studies met inclusion criteria and had analysable data on the following six outcomes: age, sex, race, education, income, or health status

2.  Across all outcomes, differences between participants and non-participants occurred, although there was a lack of consistency in the direction and the magnitude of effect

3.  To ensure that legislation does not unduly bias observational studies using medical records, thoughtful decision making by research ethics boards on the need for mandatory consent is necessary
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